Minimising the Risk of Regulatory Censure



Pharma IQ
06/01/2010

Dr. Philippe Auby Senior Medical Director, Corporate ICR France & Paediatrics, Lundbeck joins Pharma IQ to share his insights on minimising the risk of regulatory censure in paediatric clinical development. [inlinead]  
To continue reading this story get free access

RECOMMENDED